Based on our Pharmacor Ovarian Cancer advisory service, Decision Resources is offering this exclusive analyst call entitled Ovarian Cancer: Avastin Will Revolutionize Therapeutic Options and Will Pave the Way for Targeted Therapy Approvals.
Date & Time
Recorded live on Tuesday, October 25, 2011
Click here to view the invite.
To learn how you can purchase this service and access the recorded playback, please fill out the following form and a representitive will contact you: